Technical Analysis for BWAY - Brainsway Ltd.

Grade Last Price % Change Price Change
grade B 10.88 1.87% 0.20
BWAY closed up 1.87 percent on Friday, May 24, 2019, on 31 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.

Earnings due: May 29

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A N/A Up
See historical BWAY trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Hammer Candlestick Bullish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
Outside Day Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
New Downtrend Bearish 1.87%
Hot IPO Pullback Bullish Swing Setup 1.87%
Lower Bollinger Band Touch Weakness 1.87%
20 DMA Resistance Bearish 0.46%
Hot IPO Pullback Bullish Swing Setup 0.46%

Older signals for BWAY ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Brainsway is a commercial stage medical device company focused on the development and sale of non-invasive neuromodulation products using the Company’s proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD), for which Brainsway received marketing authorization from the U.S. Food and Drug Administration (FDA) in 2013 (for MDD) and in August 2018 (for OCD). Brainsway is currently conducting clinical trials of Deep TMS in other psychiatric, neurological and addiction disorders, including smoking cessation and post-traumatic stress disorder, and is planning trials for opioid addiction, fatigue in multiple sclerosis (MS) and post-stroke rehabilitation.
Neuroscience Multiple Sclerosis Psychiatry Major Depressive Disorder Neuromodulation Neurophysiology Neurotechnology Obsessive Compulsive Disorder Treatment Of Major Depressive Disorder Neuropsychology Post Traumatic Stress Disorder Treatment Of Depression Fatigue
Is BWAY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 12.3899
52 Week Low 10.3
Average Volume 21,361
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 10.8358
10-Day Moving Average 10.7382
Average True Range 0.3598
ADX 48.21
+DI 9.1494
-DI 20.0143
Chandelier Exit (Long, 3 ATRs ) 10.1206
Chandelier Exit (Short, 3 ATRs ) 11.3794
Upper Bollinger Band 11.158
Lower Bollinger Band 10.5136
Percent B (%b) 0.57
BandWidth 5.946954
MACD Line -0.1134
MACD Signal Line -0.1172
MACD Histogram 0.0038
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.64
Resistance 3 (R3) 11.55 11.22 11.51
Resistance 2 (R2) 11.22 11.02 11.26 11.47
Resistance 1 (R1) 11.05 10.90 11.13 11.13 11.43
Pivot Point 10.71 10.71 10.75 10.75 10.71
Support 1 (S1) 10.54 10.52 10.63 10.63 10.33
Support 2 (S2) 10.21 10.40 10.25 10.29
Support 3 (S3) 10.04 10.21 10.25
Support 4 (S4) 10.12